Organo Corp.

As of March 31, 2026, Organo Corp. carries a market capitalization of 5.14B, placing it among publicly traded companies globally. Its enterprise value stands at 4.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Organo Corp.'s next confirmed earnings release is scheduled for November 4, 2026.

As of March 31, 2026, Organo Corp. has 229.91M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Organo Corp. maintains a current ratio of 2.71, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 5, 2026, Organo Corp.'s stock has gained approximately 54.30% over the past 52 weeks.

As of March 31, 2026, Organo Corp. holds 535.09M in cash and equivalents against 216.80M in total debt, resulting in a net debt position of 21.09M. Total book value stands at 900.92M, with working capital of 762.92M providing operational flexibility.

Organo Corp.'s most recent stock split took place on September 29, 2026 with a 1:5 split ratio.